HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea
· Delayed Price · Currency is KRW
2,950.00
+90.00 (3.15%)
Mar 10, 2026, 3:30 PM KST
HLB Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 240,118 | 934,494 | 331,363 | 365,136 | 378,914 | 776,712 | |
| Market Cap Growth | -71.66% | 182.02% | -9.25% | -3.64% | -51.22% | 0.46% | |
| Enterprise Value | 258,855 | 946,064 | 315,400 | 359,859 | 380,861 | 785,427 | |
| Last Close Price | 2860.00 | 11152.38 | 4176.19 | 5152.98 | 6290.08 | 12980.24 | |
| PS Ratio | 3.80 | 17.01 | 6.30 | 8.61 | 8.69 | 18.09 | |
| PB Ratio | 1.41 | 5.14 | 1.93 | 2.85 | 2.91 | 7.74 | |
| P/TBV Ratio | 4.48 | 6.37 | 2.21 | 3.28 | 3.31 | 9.64 | |
| P/FCF Ratio | 49.79 | 1435.95 | 109.54 | - | - | - | |
| P/OCF Ratio | 39.25 | 725.68 | 99.60 | - | - | - | |
| EV/Sales Ratio | 4.09 | 17.22 | 6.00 | 8.49 | 8.74 | 18.30 | |
| EV/EBITDA Ratio | - | 2022.13 | - | - | - | - | |
| EV/FCF Ratio | 53.68 | 1453.73 | 104.26 | - | - | - | |
| Debt / Equity Ratio | 0.13 | 0.13 | 0.06 | 0.41 | 0.39 | 0.13 | |
| Debt / EBITDA Ratio | - | 49.91 | - | - | - | - | |
| Debt / FCF Ratio | 4.59 | 35.88 | 3.31 | - | - | - | |
| Net Debt / Equity Ratio | -0.03 | -0.08 | -0.13 | -0.09 | -0.38 | -0.15 | |
| Net Debt / EBITDA Ratio | 2.71 | -30.82 | 57.35 | 2.03 | 5.27 | 1.46 | |
| Net Debt / FCF Ratio | -0.94 | -22.16 | -7.38 | 0.97 | 4.09 | 1.32 | |
| Asset Turnover | 0.29 | 0.26 | 0.27 | 0.23 | 0.28 | 0.33 | |
| Inventory Turnover | 8.06 | 8.40 | 7.70 | 7.66 | 13.82 | 11.14 | |
| Quick Ratio | 0.92 | 1.46 | 1.58 | 1.24 | 1.91 | 1.82 | |
| Current Ratio | 1.16 | 1.70 | 1.86 | 1.37 | 2.00 | 2.07 | |
| Return on Equity (ROE) | -4.97% | -12.97% | -1.98% | -8.97% | -15.42% | -19.73% | |
| Return on Assets (ROA) | -2.22% | -2.27% | -2.85% | -2.49% | -4.45% | -5.39% | |
| Return on Capital Employed (ROCE) | -4.20% | -4.10% | -5.10% | -5.80% | -8.30% | -10.90% | |
| Earnings Yield | -3.33% | -2.44% | -0.69% | -3.11% | -4.54% | -2.18% | |
| FCF Yield | 2.01% | 0.07% | 0.91% | -3.34% | -3.19% | -1.51% | |
| Buyback Yield / Dilution | -2.60% | -6.36% | -14.46% | -10.86% | -7.26% | -4.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.